Utah Medical Products Reports Q1 2025 Financial Results

Utah Medical Products ( (UTMD) ) has released its Q1 earnings. Here is a breakdown of the information Utah Medical Products presented to its investors.

Utah Medical Products, Inc. is a company specializing in the development, manufacturing, and marketing of medical devices, primarily focusing on healthcare for women and infants, with a global reach in over 100 countries. In the first quarter of 2025, Utah Medical Products reported financial results that aligned with its projections, despite experiencing declines in key financial metrics compared to the same period in 2024. The company saw a decrease in revenues by 14.4%, gross profit by 18.1%, operating income by 18.8%, and net income by 23.1%. Earnings per share also fell by 16.0%, reflecting a challenging quarter. The decline in revenue was largely driven by reduced sales to PendoTECH, while domestic sales excluding PendoTECH showed a 9% increase. Despite the overall decline in financial performance, the company maintained a strong balance sheet with a slight increase in cash and investments. Looking forward, Utah Medical Products’ management remains committed to achieving its financial targets for 2025, with expectations of consistent revenue performance for the remainder of the year.